Search for: "TAKEDA PHARMACEUTICALS USA, INC" Results 21 - 40 of 41
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
6 Aug 2012, 1:24 pm by Brenda Fulmer
This first lawsuit was filed in the San Francisco County Superior Court asserting that AstraZeneca Pharmaceuticals, Inc. and Takeda Pharmaceuticals USA, Inc. failed to conduct adequate and sufficient post-marketing surveillance of adverse events caused by ingestion of Nexium and Prevacid after they began marketing the drug. [read post]
14 Nov 2008, 2:08 am
You can separately subscribe to the Pharma & Biotech edition of the IP Think Tank Global Week in Review by subscribing by email, or selecting ‘all posts’ or ‘Pharma, Biotech & Chem’ for the RSS option at the Subscribe page: [duncanbucknell.com]   Highlights this week included: Plavix (Clopidogrel) - Canada: Selection patents upheld by Supreme Court: Apotex v Sanofi-Synthelabo Canada (Jeremy de Beer) (ipblog.ca) (Excess Copyright)… [read post]
27 Jan 2012, 7:13 am by Ed Wallis
As a result, the FDA ordered the drug’s manufacturer, Takeda Pharmaceuticals North America, Inc., to update Actos symptoms on the drug’s label earlier this fall. [read post]
18 Mar 2010, 2:30 am
Teva Pharmaceuticals USA, Inc. et al. and Gilead Sciences, Inc., et al. v. [read post]
2 Sep 2010, 10:51 am by Dennis Crouch
Teva Pharmaceuticals USA, Inc., 566 F.3d 989 (Fed. [read post]
7 Dec 2023, 1:47 pm by Dennis Crouch
Teva Pharmaceuticals USA, Inc., 7 F.4th 1320, 1333 (Fed. [read post]
26 Jan 2010, 7:06 am
Glocer ** Chief Executive Officer, Thomson Reuters, USA Yasuchika Hasegawa ** President and Chief Executive Officer, Takeda Pharmaceutical Company, Japan Hartmut Ostrowski ** Chairman and Chief Executive Officer, Bertelsmann, Germany Jim Wallis ** Editor-in-Chief and Chief Executive Officer, Sojourners, USA Muhammad Yunus ** Managing Director, Grameen Bank, Bangladesh ** confirmed for this session  Skills Creation: The Future of Employment Date:… [read post]
28 Dec 2012, 1:57 pm by Bexis
McNeil Consumer & Specialty Pharmaceuticals, 672 F.3d 372 (5th Cir. 2012). [read post]